DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas

Melissa A. Hopper(Mayo Clinic in Arizona), Anne J. Novak(Mayo Clinic)

Blood Cancer Journal

October 9, 2024

10.1038/s41408-024-01145-0

Cited by 3

Related Papers

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

|Nature Genetics|2013|211

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

|Nature Genetics|2014|175

A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase–regulated mammalian target of rapamycin activation

|Blood|2009|52